Abstracts tagged "Rheumatoid arthritis (RA)"

Abstract Number: 1335 • 2013 ACR/ARHP Annual Meeting
Sarcopenia Is Associated With Joint Damage In Rheumatoid Arthritis patients a Cross Sectional Study In a Peruvian Population
Erika Noriega¹, Rocio V. Gamboa-Cardenas¹, Manuel F. Ugarte-Gil^2,3, Mariela Medina-Chinchon², Francisco Zevallos-Miranda², J. Mariano Cucho-Venegas², Risto A. Perich-Campos^2,4, Jose L. Alfaro-Lozano², Zoila Rodriguez-Bellido^2,4 and Cesar A. Pastor-Asurza^2,4, ¹Rheumatology, Hospital Almenara, Lima, Peru, ²Rheumatology, Hospital Guillermo Almenara, EsSalud, Lima, Peru, ³Universidad Cientifica del Sur, Lima, Peru, ⁴Universidad Nacional Mayor de San Marcos, Lima, Peru
Background/Purpose: Sarcopenia is a low-level, smoldering inflammatory state driven by cytokines and oxidative stress. In rheumatoid arthritis (RA) the relationship between sarcopenia and severity of…
Abstract Number: 224 • 2013 ACR/ARHP Annual Meeting
Ultrasound Evaluation Of Joints, Tendons and Subcutaneous Tissue Of Hands In 74 Scleroderma Patients
Anat Scheiman-Elazary¹, Ami Ben-Artzi², Suzanne Kafaja², V Ranganath³, Nabeel Borazan⁴, Philip J. Clements⁵ and Daniel Furst⁶, ¹Rheumatology, Rheumatology UCLA, Los Angeles, CA, ²David Geffen School of Medicine, UCLA, Los Angeles, CA, ³Medicine, Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA, ⁴Medicine, Rheumatology UCLA, Los Angeles, CA, ⁵University of California, Los Angeles, Department of Medicine, Los Angeles, CA, ⁶Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA
Background/Purpose: A previous ultrasound study of the hands in scleroderma (SSC) and rheumatoid arthritis (RA), found mild inflammatory changes in the tendons and joints of…
Abstract Number: 2644 • 2013 ACR/ARHP Annual Meeting
Phase IB/Iia Study On Intravenous Administration Of Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells In Refractory Rheumatoid Arthritis Patients
JM Alvaro-Gracia¹, Juan A. Jover², Rosario Garcia-Vicuña³, Luis Carreño⁴, Alberto Alonso⁵, Sara Marsal⁶, Francisco J. Blanco⁷, Víctor M. Martínez-Taboada⁸, Peter C. Taylor⁹, Federico Díaz-González¹⁰ and Lydia Dorrego¹¹, ¹Unidad de Terapias Biológicas. Servicio de Reumatología, Hospital Universitario de La Princesa, Madrid, Spain, ²Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ³Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ⁴Rheumatology, Gregorio Marañón Hospital, Madrid, Spain, ⁵Hospital de Cruces, Bilbao, Spain, ⁶Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ⁷INIBIC-Hospital Universitario A Coruña. Rheumatology Division. Genomic Group, A Coruña, Spain, ⁸Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV., Santander, Spain, ⁹NDORMS, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, ¹⁰Hospital Universitario de Canarias, La Laguna. Tenerife, Spain, ¹¹TiGenix, Tres Cantos, Spain
Background/Purpose: Expanded adipose-derived stem cells (eASCs) are shown to have immune-modulatory effects both in vitro and in animal models of arthritis. eASCs are currently under…
Abstract Number: 1952 • 2013 ACR/ARHP Annual Meeting
The Value Of An Automated Ultrasound System In The Detection Of Synovitis
Ruediger Mueller¹, Mathias Gruenke², Joerg Wendler³, Florian Schuch³, Karina Hofmann-Preiss⁴, Ina Boettger⁴, Ruediger Jakobs⁵, Hendrik Schulze-Koops⁶ and Johannes von Kempis¹, ¹Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, ²Division of Rheumatoloy, Medizinische Klinik IV, University of Munich, Munich, Germany, ³Schwerpunktpraxis Rheumatologie, Erlangen, Germany, ⁴Institut für bildgebende Diagnostik und Therapie, Erlangen, Germany, ⁵Siemens AG, Erlangen, Germany, ⁶Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany
Background/Purpose: The detection of joint swelling caused by synovitis is important for the diagnosis and assessment of inflammatory arthritis. Ultrasound (US) and MRI have proven…
Abstract Number: 1291 • 2013 ACR/ARHP Annual Meeting
COVA322: Overcoming Limitations Of Current Biologics In Rheumatoid Arthritis By a Novel, Bispecific Tumor-Necrosis-Factor-Alpha / Interleukin-17A (TNF/IL-17A) Inhibitor Moving Towards The Clinic
Dragan Grabulovski, Michela Silacci, Nadja Baenziger-Tobler, Wibke Lembke, Wenjuan Zha, Richard Woods, Isabella Attinger-Toller, Roger Santimaria, Susann Koenig-Friedrich, Ulrike von der Bey, Mathias Locher and Julian Bertschinger, Covagen AG, Schlieren, Switzerland
Background/Purpose: Biologic treatment options such as TNF inhibitors have revolutionized the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), psoriasis and psoriatic arthritis. However, there…
Abstract Number: 190 • 2013 ACR/ARHP Annual Meeting
A Meta-Analysis and Systematic Literature Review: Effect Of The Method Used To Measure Adherence In Rheumatoid Arthritis On Its Rate, and Evaluation Of Associated Factors
Anat Scheiman-Elazary¹, Cortney Shourt², M. Cameron Hay³ and Daniel Furst⁴, ¹Rheumatology, Rheumatology UCLA, Los Angeles, CA, ²Rheumatology UCLA, Los Angeles, CA, ³Anthropology Miami University, Oxford, OH, ⁴Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA
Background/Purpose: Adherence reported in the literature for RA varies widely (49.5-98%)1. This variability may result in part from different methods used to measure adherence. Our…
Abstract Number: 2486 • 2013 ACR/ARHP Annual Meeting
Clinical Performance Of 4 Methods For Detecting Latent Tuberculosis Infection (LTbI) In Patients With Active Chronic Inflammatory Arthritis Taking TNFα Blockers
Carina M F Gomes¹, Maria Teresa Terreri², Maria Isabel Pinto³, Karen Oseki³, Fernanda Spina⁴ and Marcelo M. Pinheiro⁵, ¹Rheumatology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, ²Pediatrics, Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil, ³Pediatrics, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁴Rheumatology Division, Universidade Federal de São Paulo Unifesp/EPM, Brazil, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁵Brazilian Registry of Spondyloarthritis, São Paulo, Brazil
Background/Purpose: About 5% of the Brazilian population has some chronic inflammatory arthropathy (CIA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PA) and juvenile…
Abstract Number: 1942 • 2013 ACR/ARHP Annual Meeting
Ultrasound Shows Tenosynovitis to be Frequently Present as Well As Sensitive to Change in RA Patients On Biologic Medication
Hilde B. Hammer, Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: Ultrasound (US) (grey scale (GS) and power Doppler (PD)) is a sensitive tool for examination of tenosynovitis in patients with rheumatoid arthritis (RA). The…
Abstract Number: 1226 • 2013 ACR/ARHP Annual Meeting
Adherence With Current Osteoporosis Treatment Guidelines Among Rheumatologists Caring For Patients With Rheumatoid Arthritis Using Items From The Fracture Risk Assessment Tool Score
Jennifer Watt¹, Andrew E. Thompson², Nicole G. H. Le Riche³ and Janet E. Pope⁴, ¹Medicine, University of Western Ontario, London, ON, Canada, ²Rheumatology, St. Josephs Health Ctr, London, ON, Canada, ³Department of Medicine, St. Joseph's Hospital, London, ON, Canada, ⁴Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Background/Purpose: To assess whether the Fracture Risk Assessment Tool (FRAX) score in patients with RA correlates with likelihood of osteoporosis (OP) prescription including drug treatment,…
Abstract Number: L12 • 2013 ACR/ARHP Annual Meeting
Cetrorelix, a Gonadotropin-Releasing Hormone Antagonist, Demonstrates Efficacy and Significantly Reduces Proinflammatory Cytokines in Patients with Active Longstanding Rheumatoid Arthritis with High Gonadotropin Levels: A Proof-of-Concept, Double-Blind, Randomized Trial
Anita Kåss^1,2, Ivana Hollan³, Peter Torjesen⁴, Hans Christian Gulseth⁵ and Øystein T. Førre⁶, ¹Faculty of Medicine, University of Oslo, Oslo, Norway, ²Dept. of Rheumatology, Betanien Hospital, Skien, Norway, ³Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, ⁴Department of Endocrinology, Oslo University Hospital, Oslo, Norway, ⁵Rheumatology, Betanien Hospital, Skien, Norway, ⁶Oslo University Hospital, Oslo, Norway
Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is unclear, and treatment options can be improved. Gonadotropin-releasing hormone (GnRH) stimulates immune responses (1). Inhibiting GnRH, by…
Abstract Number: 2413 • 2013 ACR/ARHP Annual Meeting
Expression and Function Of a YAP, a Novel Pathway In Fibroblast-Like Synoviocyte In Rheumatoid Arthritis
Beatrix Bartok, Rheumatology, UCSD School of Medicine, La Jolla, CA
Background/Purpose: Modulating molecular pathways that regulate pathogenic behavior fibroblast-like synoviocytes (FLS) could lead to new therapies for rheumatoid arthritis (RA). Targeting transcription factors are especially…
Abstract Number: 1944 • 2013 ACR/ARHP Annual Meeting
Ultrasound Characteristics Of Extensor Tendon Abnormalities and Peritendinous Fluid In Rheumatoid Arthritis
Laurie Ann Ramrattan¹ and Gurjit S. Kaeley², ¹Internal Medicine, University of Florida, Jacksonville, FL, ²College of Medicine, University of Florida, Jacksonville, FL
Background/Purpose: Rheumatoid arthritis (RA) is synonymous for involving synovial lined structures such as joints and tendon sheaths. Alterations in the extensor tendons overlying the metacarpophalangeal…
Abstract Number: 1051 • 2013 ACR/ARHP Annual Meeting
Sociodemographic, Health System, and Community Characteristics Associated With Initiation Of Biological Dmards In RA
Edward H. Yelin¹, Chris Tonner², Seoyoung C. Kim³, Jeffrey N. Katz⁴, John Z. Ayanian⁵ and Daniel H. Solomon⁶, ¹Medicine, UC San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ⁵Brigham and Women's Hospital, Boston, MA, ⁶Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA
Background/Purpose: The use of biologic DMARDs for RA has improved outcomes, but it is unknown whether there are disparities in initiation of these agents by…
Abstract Number: 2429 • 2013 ACR/ARHP Annual Meeting
Enhanced Responsiveness To Stimulation and Increased Extrusion Of Extracellular Traps By Rheumatoid Arthritis Neutrophil Granulocytes and of Healthy Control Neutrophils to Serum and Synovial Fluid From Rheumatoid Arthritis Patients
Stavros Giaglis^1,2, Chanchal Sur Chowdhury³, Ulrich A. Walker⁴, Andreas Buser⁵, Sinuhe Hahn⁶ and Paul Hasler¹, ¹Dept. of Rheumatology, Kantonsspital Aarau, Aarau, Switzerland, ²Dept. of Biomedicine, Laboratory of Prenatal Madicine, University Hospital Basel, Basel, Switzerland, ³Dept. of Biomedicine, Laboratory of Prenatal Diagnostics, University Hospital Basel, Basel, Switzerland, ⁴Department of Rheumatology, University Hospital Basel, Basel, Switzerland, Basel, Switzerland, ⁵Division of Hematology; Swiss Red Cross Blood Transfusion Centre, University Hospital Basel, Basel, Switzerland, ⁶Dept. of Biomedicine, Laboratory for Prenatal Medicine, University Hospital Basel, Basel, Switzerland
Background/Purpose: Polymorphonuclear granulocytes (PMNs) are the most abundant immune cell population in the synovial fluid in the joints of patients with rheumatoid arthritis (RA) and…
Abstract Number: 1943 • 2013 ACR/ARHP Annual Meeting
Results of a Reliability Exercise for the Grading of Tendon Rupture in Patients With Rheumatoid Arthritis, using a Consensus-Based Ultrasound Score
George A. W. Bruyn¹, Petra Hanova², Annamaria Iagnocco³, Maria-Antonietta d'Agostino⁴, Lene Terslev⁵, I. Moller⁶, Peter V. Balint⁷, E. Filippucci⁸, Carlos Pineda⁹, Marina Backhaus¹⁰, Richard van Vugt¹¹, Richard J. Wakefield¹², Paul Baudoin¹³, Kei Ikeda¹⁴, Artur Bachta¹⁵, Helen I. Keen¹⁶, Levent Oczakar¹⁷, Sibel Z. Aydin¹⁸, Marwin Gutierrez¹⁹, Peter Mandl²⁰ and Esperanza Naredo²¹, ¹Dept of Rheumatology, MC Groep hospitals, Lelystad, Netherlands, ²Institute of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, ³Sapienza University of Rome, Rome, Italy, ⁴Rheumatology, Versailles-Saint Quentin en Yvelines University- APHP, Ambroise-Paré Hospital, Boulogne-Billancourt, France, ⁵The Parker Institute, Copenhagen, Denmark, ⁶Instituto Poal, Barcelona, Spain, ⁷Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, ⁸University Politecnica delle Marche, Ancona, Italy, ⁹Biomedical Research, Instituto Nacional de Rehabilitacion, Mexico City, Mexico, ¹⁰Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, ¹¹VU Medisch Centrum, Amsterdam, Netherlands, ¹²Division of Rheumatic and Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, ¹³MC Groep hospitals, Lelystad, Netherlands, ¹⁴Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan, ¹⁵Military Medical Institute, Warsaw, Poland, ¹⁶School of Medicine and Pharmacology, The University of Western Australia, Crawley, Australia, ¹⁷Hacettepe University Medical School, Ankara, Turkey, ¹⁸Unit of Rheumatology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey, ¹⁹Università Politecnica delle Marche, Jesi, Italy, ²⁰Medical University of Vienna, Vienna, Austria, ²¹Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Background/Purpose: To develop the first ultrasound (US) scoring system of tendon rupture in rheumatoid arthritis (RA) and assess its intra- and inter-observer reliability. Methods: We…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].